Institute of Disaster and Emergency Medicine, Tianjin University, Tianjin, China.
Tianjin Key Laboratory of Disaster Medicine Technology, Tianjin, China.
Stem Cell Res Ther. 2022 Apr 1;13(1):135. doi: 10.1186/s13287-022-02808-0.
FeO magnetic nanoparticles (MNPs) are biomedical materials that have been approved by the FDA. To date, MNPs have been developed rapidly in nanomedicine and are of great significance. Stem cells and secretory vesicles can be used for tissue regeneration and repair. In cell therapy, MNPs which interact with external magnetic field are introduced to achieve the purpose of cell directional enrichment, while MRI to monitor cell distribution and drug delivery. This paper reviews the size optimization, response in external magnetic field and biomedical application of MNPs in cell therapy and provides a comprehensive view.
FeO 磁性纳米颗粒(MNPs)是已获得 FDA 批准的生物医学材料。迄今为止,MNPs 在纳米医学中发展迅速,具有重要意义。干细胞和分泌小泡可用于组织再生和修复。在细胞治疗中,引入与外部磁场相互作用的 MNPs 以实现细胞定向富集的目的,同时通过 MRI 监测细胞分布和药物递送。本文综述了 MNPs 在细胞治疗中的尺寸优化、对外磁场的响应及生物医学应用,提供了全面的观点。
Stem Cell Res Ther. 2022-4-1
Nanomedicine (Lond). 2014-4
Recent Pat Drug Deliv Formul. 2017
Nanotechnology. 2019-9-6
J Biomed Mater Res A. 2016-5
Adv Colloid Interface Sci. 2019-1-23
Nanomaterials (Basel). 2025-8-5
Regen Ther. 2025-7-23
Bioengineering (Basel). 2025-6-16
Nanomaterials (Basel). 2024-12-17